Evidence map›Paper›PMID 34535490›Full record

ReviewBMJ global health2021

'Learn from the lessons and don't forget them': identifying transferable lessons for COVID-19 from meningitis A, yellow fever and Ebola virus disease vaccination campaigns.

Julie Collins, Rosie Westerveld, Kate A Nelson, Hana Rohan, Hilary Bower, Siobhan Lazenby, Gloria Ikilezi, Rebecca Bartlein, Daniel G Bausch, David S Kennedy

Abstract readReview
In one paragraph

Review in BMJ global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Importance of Targeted Communication Strategies During COVID-19 Vaccination Campaigns in Mozambique: Results of a Mixed-Methods Acceptability Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  7. Multilevel approaches to immunization equity.Current opinion in immunology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The RTS,S malaria vaccine: Journey from conception to recommendation.Public health in practice (Oxford, England) · 2022
    Article
  16. Article
  17. Role conflict, job crafting, stress and resilience among nurses during COVID-19.Journal of contingencies and crisis management · 2022
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Julie CollinsUK Public Health Rapid Support Team, London School of Hygiene & Tropical Medicine/Public Health England, London, UK julie.collins@lshtm.ac.uk.ORCID 0000-0002-0673-3649
Rosie WesterveldDepartment of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
Kate A NelsonDepartment of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.ORCID 0000-0001-7747-1482
Hana RohanUK Public Health Rapid Support Team, London School of Hygiene & Tropical Medicine/Public Health England, London, UK.ORCID 0000-0002-5327-6348
Hilary BowerUK Public Health Rapid Support Team, London School of Hygiene & Tropical Medicine/Public Health England, London, UK.ORCID 0000-0002-1541-6637
Siobhan LazenbyGates Ventures, Kirkland, Washington, USA.
Gloria IkileziGates Ventures, Kirkland, Washington, USA.
Rebecca BartleinGates Ventures, Kirkland, Washington, USA.
Daniel G BauschUK Public Health Rapid Support Team, London School of Hygiene & Tropical Medicine/Public Health England, London, UK.
David S KennedyUK Public Health Rapid Support Team, London School of Hygiene & Tropical Medicine/Public Health England, London, UK.ORCID 0000-0003-0004-6167

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCOVID-19 vaccines are now being distributed to low- and middle-income countries (LMICs), with global urgency surrounding national vaccination plans. LMICs have significant experience implementing vaccination campaigns to respond to epidemic threats but are often hindered by chronic health system challenges. We sought to identify transferable lessons for COVID-19 vaccination from the rollout of three vaccines that targeted adult groups in Africa and South America: MenAfriVac (meningitis A); 17D (yellow fever) and rVSV-ZEBOV (Ebola virus disease).

methodsWe conducted a rapid literature review and 24 semi-structured interviews with technical experts who had direct implementation experience with the selected vaccines in Africa and South America. We identified barriers, enablers, and key lessons from the literature and from participants' experiences. Interview data were analysed thematically according to seven implementation domains.

resultsParticipants highlighted multiple components of vaccination campaigns that are instrumental for achieving high coverage. Community engagement is an essential and effective tool, requiring dedicated time, funding and workforce. Involving local health workers is a key enabler, as is collaborating with community leaders to map social groups and tailor vaccination strategies to their needs. Vaccination team recruitment and training strategies need to be enhanced to support vaccination campaigns. Although recognised as challenging, integrating vaccination campaigns with other routine health services can be highly beneficial if well planned and coordinated across health programmes and with communities.

conclusionAs supplies of COVID-19 vaccines become available to LMICs, countries need to prepare to efficiently roll out the vaccine, encourage uptake among eligible groups and respond to potential community concerns. Lessons from the implementation of these three vaccines that targeted adults in LMICs can be used to inform best practice for COVID-19 and other epidemic vaccination campaigns.

Indexed as

COVID-19Ebola VaccinesHemorrhagic Fever, EbolaMeningitisYellow FeverAdultCOVID-19 VaccinesHumansImmunization ProgramsSARS-CoV-2COVID-19 VaccinesEbola Vaccinescontrol strategiesCOVID-19immunisationqualitative study

Identifiers

PMID34535490
PMCPMC8450956

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.